Renalytix PLC (LS:A41WQD) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Retail Offer Shares Closed: £1M raised · £0.06 a share | Sep 28, 2026 | US$1.35M |
| Private placement of new ordinary shares Closed: £10.1M raised · £0.06 a share · Oberon Capital +1 Dealers: Oberon Capital (lead), SP Angel Corporate Finance LLP | Sep 28, 2026 | US$13.66M |
| Private placement of new Ordinary Shares Closed: £7.05M raised · GBX 9.5 a share · Oberon Capital +2 Dealers: Oberon Capital (lead), SP Angel Corporate Finance LLP, Winterflood Securities Ltd Buyers: Julian Baines (105,263 shares; 0.48% post Admission); Christopher Mills (2,500,000 shares; 4.21% post Admission); Robert Naylor (105,263 shares; 0.17% post Admission); Catherine Coste (105,263 shares; 0.1% post Admission) Insiders: Directors Julian Baines, Christopher Mills, Robert Naylor and Catherine Coste participated in the Fundraise Use of proceeds: Support growth and the new collaboration with Tempus AI | Sep 26, 2025 |